<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>aimeeb</title>
    <description>allthethings!
</description>
    <link>http://aimeeb.com/</link>
    <atom:link href="http://aimeeb.com/feed.xml" rel="self" type="application/rss+xml"/>
    <pubDate>Sun, 01 Mar 2015 17:57:52 -0500</pubDate>
    <lastBuildDate>Sun, 01 Mar 2015 17:57:52 -0500</lastBuildDate>
    <generator>Jekyll v2.4.0</generator>
    
      <item>
        <title>Have air fares fallen with gas?</title>
        <description>&lt;p&gt;Driving through suburban New Jersy, signs advertising $1.97 unleaded gas evoke memories of learning to drive my first car. That was when I was in high school, 12 years ago. Even to chronic pedestrians, the gas price collapse is an inescapable curiosity. Like my mother&#39;s home-cooked purple chicken, gas prices below $2 remind us of not-so-recent times past.&lt;/p&gt;
&lt;p&gt;Purchasing a plane ticket, in contrast, is still a big purchase. Drawing a relationship with gas prices is difficult: gas prices, ubiquotously and regularly displayed, cannot be ignored, while air fares must be sought out and can vary across suppliers. Gas price volatility further obscures change comparison. To get an empirical answer to the question “Have air fares fallen?”, I turned to the Bureau of Labor Statistics, the Bureau of Transportation Statistics and the West Texas Intermediate crude oil benchmark for the Consumer Price Index (CPI), air fare and gas prices from 1995 throuh 2014.&lt;/p&gt;
&lt;div id=&quot;air-fares-have-fallen-relatively-but-not-due-to-the-cost-of-gas&quot; class=&quot;section level4&quot;&gt;
&lt;h4&gt;Air fares have fallen relatively, but not due to the cost of gas&lt;/h4&gt;
&lt;p&gt;The data confirmed air fares have not fallen with the price of gas recently or historically, while they have fallen relative to other goods. Reporting on this topic explains why:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;For most of recent history, airlines have suffered from ridiculously low profit margins, as low as 1% in 2012 (source: &lt;a href=&quot;http://www.businessinsider.com/airlines-have-a-small-profit-margin-2012-6&quot;&gt;businessinsider.com&lt;/a&gt;).&lt;/li&gt;
&lt;li&gt;Airlines purchase gas with long-term contracts, locking in a current price. Gas price volatility is not reflected in short-term price changes (sources: &lt;a href=&quot;http://www.slate.com/articles/news_and_politics/politics/2014/12/fuel_prices_and_airfares_airlines_are_making_record_profits_don_t_bet_on.html&quot;&gt;slate&lt;/a&gt;, &lt;a href=&quot;http://www.washingtonpost.com/blogs/wonkblog/wp/2015/01/20/airlines-could-slash-ticket-prices-as-fuel-costs-plummet-heres-why-they-wont/&quot;&gt;washingtonpost.com&lt;/a&gt;).&lt;/li&gt;
&lt;li&gt;Unless demand falls, there is no reason to lower prices, and airlines are selling a record 85.1% of seats (source: &lt;a href=&quot;http://www.bostonglobe.com/business/2014/11/17/fuel-prices-are-lower-why-aren-airline-tickets-cheaper/6IO8Hkcy4Norm71MzAvfaJ/story.html&quot;&gt;bostonglobe.com&lt;/a&gt;).&lt;/li&gt;
&lt;li&gt;Compounding inelastic demand for air travel, recent consolidations have reduced intra-industry competition: “In a strong demand environment,” American Airlines Group president Scott Kirby said on a conference call in October, “we don’t plan to go off and just proactively cut fares” (source: &lt;a href=&quot;http://www.washingtonpost.com/blogs/wonkblog/wp/2015/01/20/airlines-could-slash-ticket-prices-as-fuel-costs-plummet-heres-why-they-wont/&quot;&gt;washingtonpost.com&lt;/a&gt;).&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;And although consumers may not be eager to realize it, air travel is a relative bargain.&lt;/p&gt;

&lt;img src=&quot;/css/images/cum_change_price_index_1995.png&quot; /&gt;

&lt;p&gt;The overall CPI increased by 55.3% since 1995 and the average cost of air travel has risen by 33.8%. So, while the real cost of air fare has fallen, the cost of gas had increased 406% since 1995 in 2011. And even following the recent price collapse, gas prices have still risen nearly 175% since 1995.&lt;/p&gt;
&lt;p&gt;A visual comparison of air and gas price changes quarter over quarter is difficult to evaluate, but a scatter plot and linear model sustains gas prices do not affect air fares.&lt;/p&gt;

&lt;img src=&quot;/css/images/quarterly-price-changes.png&quot; /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;img src=&quot;/css/images/quarterly-change-air-v-gas.png&quot; /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;p&gt;A linear model in R reports positive correlation but was not statistically significant. The probability there is no relationship in reality is nearly 50%, so we confidently reject the hypothesis quarterly changes in are fares are indepdendent of quarterly changes in gas prices.&lt;/p&gt;
&lt;pre style=&quot;border: 1px solid grey; border-radius: 5px;&quot;&gt;&lt;p style=&quot;padding: 20px&quot;&gt;Call:
lm(formula = bothChanges$quarter_change_air ~ bothChanges$quarter_change_gas)

Residuals:
    Min      1Q  Median      3Q     Max 
-9.7008 -1.8318  0.0702  2.1982  6.5770 

Coefficients:
                               Estimate Std. Error t value Pr(&amp;gt;|t|)
(Intercept)                      0.3671     0.3725   0.986    0.327
bothChanges$quarter_change_gas   0.0164     0.0230   0.713    0.478

Residual standard error: 3.218 on 76 degrees of freedom
Multiple R-squared:  0.006648,   Adjusted R-squared:  -0.006423 
F-statistic: 0.5086 on 1 and 76 DF,  p-value: 0.4779&lt;/p&gt;&lt;/pre&gt;


&lt;/div&gt;
</description>
        <pubDate>Mon, 23 Feb 2015 15:11:02 -0500</pubDate>
        <link>http://aimeeb.com/r/statistics/economics/gas/transportation/2015/02/23/Have-air-fares-fallen-with-gas.html</link>
        <guid isPermaLink="true">http://aimeeb.com/r/statistics/economics/gas/transportation/2015/02/23/Have-air-fares-fallen-with-gas.html</guid>
        
        
        <category>r</category>
        
        <category>statistics</category>
        
        <category>economics</category>
        
        <category>gas</category>
        
        <category>transportation</category>
        
      </item>
    
      <item>
        <title>Is it cold today?</title>
        <description>&lt;p&gt;The best present I got for Christmas 2014 cost $5.99 and was not intended as a gift: In anticipation of two days of skiing and having only ill-fitting options for borrowed pairs, my mother bought me a pair of Value Village snow pants.&lt;/p&gt;

&lt;p&gt;I love these snow pants with irrational fervor, and not because they look good. The snow pants are dark slate grey, just short enough to identify them as youth-sized, and unflattering to my figure. But what they lack in style, they make up for in warmth and comfort. It’s like wearing sleeping bags on your legs.&lt;/p&gt;

&lt;p&gt;I wear the pants nearly every day. They have made me a winter person. Before the pants, winter was absent the long walks I love, and now I take them as often as during other seasons. In other words: &lt;strong&gt;I don’t always go outside when it’s freezing, but when I do, I wear my snow pants.&lt;/strong&gt; &lt;/p&gt;

&lt;h2 id=&quot;is-it-cold-today&quot;&gt;Is it cold today?&lt;/h2&gt;

&lt;p&gt;Before snow pants, I spent much of my Boston and New York residencies wondering how so many humans have aggregated in such inhumane climates and how these cities continue to experience positive rates of migration. We’re all crazy. We live in climates where the battle between going outside at all loses to a House Hunters International marathon 95% of the time. Goodbye Saturdays in the park, hello coding side projects.&lt;/p&gt;

&lt;p&gt;Every year, I ask myself the same thing: Is it this cold &lt;em&gt;every&lt;/em&gt; winter? Today it was an average of 27 degrees farenheit - is that normal?&lt;/p&gt;

&lt;p&gt;From this question arose &lt;strong&gt;&lt;a href=&quot;http://weather-widgets.aimeeb.com&quot;&gt;weather-widgets.aimeeb.com&lt;/a&gt;&lt;/strong&gt;. Using the forecast.io, Google Geocode and flickr APIs, the first two widgets are:&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;&lt;strong&gt;Is it cold today?&lt;/strong&gt; determines the percentile of today’s average temperature when compared with the same date for the past 50 years.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Extreme Places&lt;/strong&gt; reports the weather of a randomly selected location from &lt;a href=&quot;http://www.weather.com/travel/news/most-extreme-places-20120809#/1&quot;&gt;the world’s most extreme places&lt;/a&gt;.&lt;/li&gt;
&lt;/ol&gt;

</description>
        <pubDate>Mon, 09 Feb 2015 13:01:23 -0500</pubDate>
        <link>http://aimeeb.com/weather/2015/02/09/is-it-cold-today.html</link>
        <guid isPermaLink="true">http://aimeeb.com/weather/2015/02/09/is-it-cold-today.html</guid>
        
        
        <category>weather</category>
        
      </item>
    
      <item>
        <title>Does Obama Veto a Lot?</title>
        <description>&lt;p&gt;Obama has issued two vetoes, the least number of vetoes of any President in history. Upon hearing this statistic, I wondered how few vetoes this is relative to other presidents historically.&lt;/p&gt;

&lt;p&gt;While investigating this question, other surprising aspects of bills surfaced:&lt;/p&gt;
&lt;ul style=&quot;list-style-type: decimal&quot;&gt;
&lt;li&gt;81% of bills introduced into congress since 1973 maintain a state of &quot;referred&quot;, indicating they have died in committee.&lt;/li&gt;
&lt;li&gt;There is evidence to support the number of bills enacted per session is declining.&lt;/li&gt;
&lt;li&gt;The congressional sessions during the Reagan presidency experienced 10 times more resolutions than the sessions before and after Reagan.&lt;/li&gt;
&lt;/ul&gt;

&lt;div id=&quot;has-congress-been-busy&quot; class=&quot;section level2&quot;&gt;
&lt;h4&gt;A majority of bills stagnate in committee.&lt;/h4&gt;
&lt;p&gt;To assess the number of relative vetoes, we will compare the number of vetoes with the number of bills enacted.&lt;/p&gt;

&lt;p&gt;There are more than just a few states a bill can be in however: Each bill record maintains a state, initiated as &quot;introduced&quot;, and progressing into as many as 29 different states. For a complete listing of these statuses, see &lt;strong&gt;Appendix A: 29 Flavors of Legislative State&lt;/strong&gt; at the bottom of this post.&lt;/p&gt;

&lt;p&gt;In order to make these states digestable, I collapsed them into 9 states: introduced, referred, reported, enacted, enacted by veto override, passed, congressional stalemante, veto, and resolution.&lt;/p&gt;

&lt;div id=&quot;of-bills-in-us-history-remain-in-a-referred-state&quot; class=&quot;section level3&quot;&gt;
&lt;h4&gt;81% of bills introduced since 1973 are in the “referred” state.&lt;/h4&gt;

&lt;p&gt;In the &lt;a href=&quot;https://www.govtrack.us/developers/api&quot;&gt;govtrack.us database there are 335,487 bills&lt;/a&gt;. While inspecting the govtrack.us database, I was interested to find how many bills stagnate in committee.&lt;/p&gt;

&lt;p&gt;If only looking back to 1973 an overwhelming majority, 81%, of bills remain in the referred state. Being referred to committee and then held at that level, as opposed to being sent to subcommittee means one of two things: either the bill will be acted on quickly or it is being suppressed and will die from neglect (&lt;a href=&quot;http://www.lexisnexis.com/help/CU/The_Legislative_Process/Stage_3.htm&quot;&gt;source: LexisNexis&lt;/a&gt;).&lt;/p&gt;

&lt;img src=&quot;/css/images/bill_statuses_pie.png&quot; /&gt;

&lt;/div&gt;

&lt;h4&gt;The total number of bills enacted by congress is declining.&lt;/h4&gt;
&lt;p&gt;By visual inspection, I surmise the number of bills enacted by Congress is declining over time.&lt;/p&gt;

&lt;img src=&quot;/css/images/bills_enacted.png&quot; /&gt;
&lt;/div&gt;
&lt;div id=&quot;reagans-congressional-sessions-introduction-of-resolutions-dwarves-those-before-and-after&quot; class=&quot;section level3&quot;&gt;
&lt;h4&gt;The number of bills introduced is also declining.&lt;/h4&gt;
&lt;p&gt;I also surmise the number of bills introduced is also declining, however visual analysis is thwarted by the Reagan sessions towering over their neighbors.&lt;/p&gt;
&lt;img src=&quot;/css/images/bills_introduced.png&quot; /&gt;

&lt;br /&gt;
&lt;br /&gt;
&lt;p&gt;It is impossible to ignore the 97th through 100th congressional sessions. Congressional activity, specifically new resolutions, spiked during Ronald Reagan’s presidency. Comparing the 4 sessions before, during and after the Reagan presidency revealed &lt;strong&gt;nearly 10 times more house resolutions from the Reagan years still exist in the introduced state as before and after the Reagan years.&lt;/strong&gt; From those sessions, 996 house resolutions are still in the “introduced” state, whereas before and after Reagan sessions only 103 and 26 house resolutions still exist as “introduced”.&lt;/p&gt;

&lt;div id=&quot;does-obama-veto-a-lot&quot; class=&quot;section level2&quot;&gt;
&lt;h4&gt;Obama has issued the least total and relative number of vetoes.&lt;/h4&gt;
&lt;p&gt;Obama has been president during the 111th, 112th and 113th Congressional sessions. Both in total and relative numbers, he has vetoed the least bills of any president since 1973.&lt;/p&gt;

&lt;img src=&quot;/css/images/proportion_vetoed.png&quot; /&gt;

&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;div id=&quot;appendix-a-29-flavors-of-legislative-state&quot; class=&quot;section level3&quot;&gt;
&lt;h3&gt;Appendix A: 29 Flavors of Legislative State&lt;/h3&gt;
&lt;div id=&quot;identity&quot; class=&quot;section level4&quot;&gt;
&lt;h4&gt;Identity&lt;/h4&gt;
&lt;ul style=&quot;list-style-type: decimal&quot;&gt;
&lt;li&gt;referred&lt;/li&gt;
&lt;li&gt;reported&lt;/li&gt;
&lt;li&gt;introduced&lt;/li&gt;
&lt;li&gt;enacted_veto_override&lt;/li&gt;
&lt;li&gt;passed_bill&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
&lt;div id=&quot;congressional-stalemate&quot; class=&quot;section level4&quot;&gt;
&lt;h4&gt;Congressional Stalemate&lt;/h4&gt;
&lt;ul style=&quot;list-style-type: decimal&quot;&gt;
&lt;li&gt;pass_over_senate&lt;/li&gt;
&lt;li&gt;pass_over_house&lt;/li&gt;
&lt;li&gt;pass_back_house&lt;/li&gt;
&lt;li&gt;pass_back_senate&lt;/li&gt;
&lt;li&gt;fail_originating_house&lt;/li&gt;
&lt;li&gt;fail_originating_senate&lt;/li&gt;
&lt;li&gt;conference_passed_house&lt;/li&gt;
&lt;li&gt;fail_second_house&lt;/li&gt;
&lt;li&gt;failed_second_senate&lt;/li&gt;
&lt;li&gt;conference_passed_senate&lt;/li&gt;
&lt;li&gt;prov_kill_suspensionfailed&lt;/li&gt;
&lt;li&gt;prov_kill_cloturefailed&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
&lt;div id=&quot;vetoed&quot; class=&quot;section level4&quot;&gt;
&lt;h4&gt;Vetoed&lt;/h4&gt;
&lt;ul style=&quot;list-style-type: decimal&quot;&gt;
&lt;li&gt;prov_kill_veto&lt;/li&gt;
&lt;li&gt;vetoed_pocket&lt;/li&gt;
&lt;li&gt;override_pass_over_house&lt;/li&gt;
&lt;li&gt;vetoed_override_fail_second_senate&lt;/li&gt;
&lt;li&gt;vetoed_override_fail_originating_house&lt;/li&gt;
&lt;li&gt;vetoed_override_fail_originating_senate&lt;/li&gt;
&lt;li&gt;vetoed_override_fail_second_house&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
&lt;div id=&quot;enacted&quot; class=&quot;section level4&quot;&gt;
&lt;h4&gt;Enacted&lt;/h4&gt;
&lt;ul style=&quot;list-style-type: decimal&quot;&gt;
&lt;li&gt;enacted_signed&lt;/li&gt;
&lt;li&gt;enacted_unknown&lt;/li&gt;
&lt;li&gt;enacted_tendayrule&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
&lt;div id=&quot;passed-resolutions&quot; class=&quot;section level4&quot;&gt;
&lt;h4&gt;Passed Resolutions&lt;/h4&gt;
&lt;ul style=&quot;list-style-type: decimal&quot;&gt;
&lt;li&gt;passed_concurrentres&lt;/li&gt;
&lt;li&gt;passed_simpleres&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;&lt;em&gt;simple resolution:&lt;/em&gt;&lt;/strong&gt; Designated “S. Res.,” simple resolutions are used to express nonbinding positions of the Senate or to deal with the Senate’s internal affairs, such as the creation of a special committee. They do not require action by the House of Representatives. (&lt;a href=&quot;https://www.senate.gov/reference/glossary_term/simple_resolution.htm&quot;&gt;source&lt;/a&gt;)&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div id=&quot;resources&quot; class=&quot;section level3&quot;&gt;
&lt;h3&gt;Resources&lt;/h3&gt;
&lt;p&gt;&lt;a href=&quot;http://mathematicalcoffee.blogspot.com/2014/06/ggpie-pie-graphs-in-ggplot2.html&quot;&gt;http://mathematicalcoffee.blogspot.com/2014/06/ggpie-pie-graphs-in-ggplot2.html&lt;/a&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;


&lt;/div&gt;
</description>
        <pubDate>Mon, 26 Jan 2015 17:13:37 -0500</pubDate>
        <link>http://aimeeb.com/r/politics/statistics/2015/01/26/does-obama-veto-alot.html</link>
        <guid isPermaLink="true">http://aimeeb.com/r/politics/statistics/2015/01/26/does-obama-veto-alot.html</guid>
        
        
        <category>r</category>
        
        <category>politics</category>
        
        <category>statistics</category>
        
      </item>
    
      <item>
        <title>Is the fitbit the solution to our weight problem?</title>
        <description>&lt;p&gt;The fitbit dominates the wearable technology conversation offering an accessible tool to improve your health. It has emerged as the leader of the activity trackers market: according to &lt;a href=&quot;http://mobihealthnews.com/28566/fitbit-shipped-the-most-activity-trackers-in-2013/&quot;&gt;mobihealthnews&lt;/a&gt;, fitbit shipped 67% of all activity tracking devices in 2013 and according to &lt;a href=&quot;http://www.canalys.com/newsroom/fitbit-accounted-nearly-half-global-wearable-band-shipments-q1-2014&quot;&gt;Canalys&lt;/a&gt; sustained 50% market share in 2014.
We see its success in aggregate and in every day encounters: My mom has a fitbit and she loves it and it has worked for her. She often takes walks after dinner to make up for “surplus energy consumption” (i.e. overeating), revealed to her by the fitbit. And she has lost weight after a long-running plateau.&lt;/p&gt;

&lt;h4 id=&quot;does-it-work-in-general&quot;&gt;Does it work in general?&lt;/h4&gt;

&lt;p&gt;Fitbit claims it does: in an article by &lt;a href=&quot;http://www.entrepreneur.com/article/223780&quot;&gt;entrepreneur.com&lt;/a&gt;, fitbit reports its users demonstrate a 43% increase in steps per day and report an average weight loss of 13 pounds when they have weight loss goals.
There are, at the time of this writing, 29 studies listed on clinicaltrials.gov for the search term “fitbit”. Of those, only 4 have been completed.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/css/images/fitbit_target_enrollment.png&quot; /&gt;&lt;/p&gt;

&lt;h4 id=&quot;a-study-of-medical-residents&quot;&gt;A study of medical residents&lt;/h4&gt;

&lt;p&gt;Of the 4 completed trials, only one had posted results. Luckily, the single completed study with posted results fascinated me: &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065028/&quot;&gt;the study&lt;/a&gt; observed the effects of the fitbit on activity levels in hospital residents. Originating from the premise those who medically advise us should themselves be role models of health, the study argues not only does the work of medical professionals itself suffer as a result of unhealthy habits, but it’s also been shown to increase the probabilty of recommending healthy habits to patients. The demanding schedules of residents underlies this problem: the rate of burnout is higher than for other professions.&lt;/p&gt;

&lt;p&gt;Out of the 127 residents at Massachusetts General Hospital in, 104 participated in the 12-week trial in two 6-week phases. During the first phase, half of the residents were “blind” as the control arm: they wore a fitbit but were unable to see their activity levels. The other half were “unblinded” as the intervention arm: they wore a fitbit and were able to see their activity levels displayed in real time and on the fitbit web application. During the second phase, all residents were unblinded and participated in a three team competition of most average steps per day.&lt;/p&gt;

&lt;p&gt;A number of things surprised me about this trial and its results, some of weaken fitbit’s claims of efficacy: &lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Nearly all of the 127 residents participated, suggesting an residents are highly motivated and optimistic about the fitbit itself and / or its outcomes.&lt;/li&gt;
  &lt;li&gt;Residents take just under 8,000 steps a day, well above the national average of 5,117 as reported in the entrepreneur article, but still below the 10,000 recommended by the U.S. Surgeon General. Average steps per day was negligibly greater for the intervention group than the control group.&lt;/li&gt;
  &lt;li&gt;Compliance fell during the second phase.&lt;/li&gt;
  &lt;li&gt;The most promising finding of this trial is the participation rate. Even within a busy hospital setting and with demanding schedules, 85% of residents participated and demonstrated 77% compliance over a 12-week period. It is also impossible to know the effect on average steps per day of just wearing an activity monitor, as all subjects wore an activity tracker and understood their steps were being counted. But, the study agrees that other methods - or perhaps just more residents and thus more relaxed schedules - are needed to make a real difference.&lt;/li&gt;
&lt;/ul&gt;

&lt;h4 id=&quot;results-on-the-horizon&quot;&gt;Results on the horizon&lt;/h4&gt;

&lt;p&gt;More data should flow from the active studies. However, fitbit trials are different from what’s considered a “typical clinical trial”: sponsored by a big pharma company, a typical trial investigates the effect of some intervention with the goal of FDA approval of that intervention. Fitbit has no need for FDA approval so studies are uncharactersitcally heterogeneous.&lt;/p&gt;

&lt;p&gt;The characteristics of fitbut studies are:&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;1. Trial sponsors are involved in only one or two trials and tend to be mostly universities, foundations and healthcare institututes.&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Below is a comprehensive list of these sponsors (note, more than one sponsor can be involved in a single trial).&lt;/p&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;Sponsor&lt;/th&gt;
      &lt;th style=&quot;text-align: right&quot;&gt;Number of fitbit studies&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Aalborg Universitetshospital&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Aalborg University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Arizona State University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Baycrest Centre for Geriatric Care&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Canadian Institutes of Health Research  (CIHR)&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Carol Fabian, MD&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Carol Vassiliadis Family&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Children’s Hospital of Eastern Ontario&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Danish Heart Foundation&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Dr Falk Mueller-Riemenschneider&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;DSM Nutritional Products, Inc.&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;EIR (Empowering Industry and Research)&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Emory University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Frederikshavn Municipality&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;GP in the Municipalities of Hjoerring and Frederikshavn&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Grand Valley State University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Health Promotion Board, Singapore&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Hjoerring Municipaility&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;International Business Machines (IBM)&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;JR Albert Foundation&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Julie Wang&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Katholieke Universiteit Leuven&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;KMD&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;M.D. Anderson Cancer Center&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Mayo Clinic&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;McMaster University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Medidata Solutions&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Miami Research Associates&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;National Heart, Lung, and Blood Institute (NHLBI)&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;National University, Singapore&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;New York CFS Association&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;New York University School of Medicine&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Northwestern University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Oakland University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Oscar Film&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Phonak AG, Switzerland&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Renal Research Institute&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Roche Pharma AG&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Seattle Children’s Hospital&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Simon Fraser University&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;SOS International&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Spectrum Health Hospitals&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Tel-Aviv Sourasky Medical Center&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Tunstall Healthcare&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;University of Aarhus&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;University of California, San Diego&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;University of Kansas&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;University of Toronto&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Vendsyssel Hospital&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Arthritis Research Centre of Canada&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;2&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Duke-NUS Graduate Medical School&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;2&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Massachusetts General Hospital&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;2&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;University of California, San Francisco&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;2&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Vancouver General Hospital&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;2&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;University of British Columbia&lt;/td&gt;
      &lt;td style=&quot;text-align: right&quot;&gt;3&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;p&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;2. Half of trials are focused on prevention, while the other half are mostly focused on treatment.&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/css/images/fitbit_primary_purpose.png&quot; /&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;3. Most trials are using parallel assignment, meaning more than one arm of treatment is being administered.&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/css/images/fitbit_intervention_model.png&quot; /&gt;&lt;/p&gt;

&lt;p&gt;As stated, there is insufficient data to state the fitbit’s effectiveness on health outcomes. But stay tuned, there is more data coming! I posit the activity trackers are making a significant difference on the lives of their consumers, based on personal experience, the enthusiasm of consumers and the growth of the market.&lt;/p&gt;
</description>
        <pubDate>Thu, 22 Jan 2015 16:41:56 -0500</pubDate>
        <link>http://aimeeb.com/r/health/clinical/trials/2015/01/22/is-fitbit-the-solution.html</link>
        <guid isPermaLink="true">http://aimeeb.com/r/health/clinical/trials/2015/01/22/is-fitbit-the-solution.html</guid>
        
        
        <category>r</category>
        
        <category>health</category>
        
        <category>clinical</category>
        
        <category>trials</category>
        
      </item>
    
      <item>
        <title>Who is looking for an ebola vaccine?</title>
        <description>&lt;p&gt;The number of studies listed on clinicaltrials.gov for ebola, 25, is less than for the fitbit, 26. This came as a surprise and led to further review of both sets of trials.&lt;/p&gt;

&lt;p&gt;The set of studies targeting the ebola virus share the follow characteristics:&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;The majority of ebola studies were started in the past year (2014).&lt;/li&gt;
  &lt;li&gt;A majority of ebola trials have been sponsored by the US Government.&lt;/li&gt;
  &lt;li&gt;The most active sponsors have only become active in the past year.&lt;/li&gt;
  &lt;li&gt;Nearly all studies are Phase I studies.&lt;/li&gt;
&lt;/ol&gt;

&lt;h4 id=&quot;the-majority-of-ebola-studies-were-started-in-the-past-year-2014&quot;&gt;&lt;strong&gt;1. The majority of ebola studies were started in the past year (2014).&lt;/strong&gt;&lt;/h4&gt;

&lt;p&gt;16 out of the 25 studies listed were started in the past year (2014).&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/css/images/ebola_studies_target_enrollment.png&quot; /&gt;&lt;/p&gt;

&lt;p&gt;One study stands out in the plot above. In 2003, an uncommonly expansive study was launched by the US Department of Health. The National Institute of Allergy and Infectious Diseases (NIAID) in collaboration with the National Institutes of Health Clinical Center (CC) launched the study &lt;a href=&quot;https://clinicaltrials.gov/show/NCT00068926&quot;&gt;Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases&lt;/a&gt;. The magnitude of the study’s enrollment target, 958, underlied its objective: funnel eligible subjects into trials for one of many “vaccines of interest” at NIAID’s Vaccine Research Center.&lt;/p&gt;

&lt;p&gt;An overview of the types of vaccines the NIAID was interested in testing:&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;Of interest are vaccines for: newly identified infectious diseases such as SARS; infectious diseases of concern as possible bioweapons, such as smallpox and Ebola virus; emerging infectious diseases that are more widespread geographically than in the past, such as West Nile virus; and, for preventing diseases such as tuberculosis and malaria.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;h4 id=&quot;a-majority-of-ebola-trials-have-been-sponsored-by-the-us-government&quot;&gt;&lt;strong&gt;2. A majority of ebola trials have been sponsored by the US Government.&lt;/strong&gt;&lt;/h4&gt;

&lt;p&gt;&lt;img src=&quot;/css/images/total_studies_by_sponsor.png&quot; /&gt;&lt;/p&gt;

&lt;p&gt;The National Institute of Allergy and Infectious Diseases (NIAID) is a sponsor in 40% of ebola trials. Also in the top 3 sponsors is the National Institutes for Health Clinical Center (CC)). NIAID and CC are both part of the US Department of Health and Human Services and together take part in two-thirds of ebola trials.&lt;/p&gt;

&lt;h4 id=&quot;the-most-active-sponsors-have-only-become-active-in-the-past-year&quot;&gt;&lt;strong&gt;3. The most active sponsors have only become active in the past year.&lt;/strong&gt;&lt;/h4&gt;

&lt;p&gt;Many new sponsors have become active in sponsoring ebola trials in the past year.
Qualifying &lt;strong&gt;active sponsors&lt;/strong&gt; as sponsors which have been involved in 3 or more trials, all active sponsors, aside from those affiliated with the US government, have become involved only in the past year. While the US Department of Defense, NIAID and CC have been sponsoring trials since 2003, in 2014, 6 other sponsors have been involved in 3 or more trials.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/css/images/active_sponsors.png&quot; /&gt;&lt;/p&gt;

&lt;h4 id=&quot;nearly-all-studies-are-phase-i-studies&quot;&gt;&lt;strong&gt;4. Nearly all studies are Phase I studies.&lt;/strong&gt;&lt;/h4&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;Phase&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;Number of Studies&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Phase 1&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;20&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Phase 1 / Phase 2&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;2&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Phase 2&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Phase 2 / Phase 3&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;1&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;p&gt;&lt;br /&gt;
Phase I studies focus on the safety, rather than the efficacy, of a treatment. Neither a vaccine nor a treatment for ebola is near or even on its way to FDA approval and the wider market.&lt;/p&gt;

</description>
        <pubDate>Sun, 28 Dec 2014 04:37:23 -0500</pubDate>
        <link>http://aimeeb.com/r/clinical/data/2014/12/28/a-survey-of-ebola-trials.html</link>
        <guid isPermaLink="true">http://aimeeb.com/r/clinical/data/2014/12/28/a-survey-of-ebola-trials.html</guid>
        
        
        <category>r</category>
        
        <category>clinical</category>
        
        <category>data</category>
        
      </item>
    
      <item>
        <title>The end of the NFL</title>
        <description>&lt;h1 id=&quot;plagued-by-head-injuries&quot;&gt;Plagued by head injuries&lt;/h1&gt;

&lt;p&gt;Journalists predicting &lt;a href=&quot;http://grantland.com/features/cte-concussion-crisis-economic-look-end-football/&quot;&gt;the end of the NFL&lt;/a&gt; cite lawsuits by
current and former players suffering &lt;a href=&quot;http://en.wikipedia.org/wiki/Concussions_in_American_football&quot;&gt;concussions&lt;/a&gt; and head
injuries. Alongside these lawsuits are reports of violent controversies in
players’ personal lives.&lt;/p&gt;

&lt;p&gt;What’s worse is these two trends are related: according to &lt;a href=&quot;https://sports.vice.com/article/the-nfl-concussion-settlement-is-pure-evil&quot;&gt;vice sports&lt;/a&gt;, 
doctors examining former players at Boston University linked
their football-related brain injuries to depression and impulse control.
Heeding these injuries, parents of potential NFL players are forbidding
participation in the sport, and conscientious fans  are second-guessing their
devotion to the game.&lt;/p&gt;

&lt;p&gt;However, in spite of all this, I continue to watch football, as do an
increasing number of Americans (and the English! American football is
enjoyed by the mayor of London, &lt;a href=&quot;http://profootballtalk.nbcsports.com/2014/11/13/mayor-says-london-is-overjoyed-to-have-nfl-games/&quot;&gt;Boris Johnson&lt;/a&gt;).&lt;/p&gt;

&lt;h1 id=&quot;ever-more-powerful-players&quot;&gt;Ever-more powerful players&lt;/h1&gt;

&lt;p&gt;An aspect of sports that as always been of interest is the continuous
advancement of athletes in the same sport over time. Athletes, over time with
advances in nutrition and training seem to get better and better. How good
they get and how long will it take to get there?&lt;/p&gt;

&lt;p&gt;In American Football, players are getting ever more powerful. This has translated
into a greater probability of conversion for any given play over time. This is
shown in the scatterplot below, using data from &lt;a href=&quot;http://www.pro-football-reference.com/play-index/play_finder.cgi&quot;&gt;pro-football-reference.com
&lt;/a&gt;. If you take this to its extreme where every play
results in a first down, the game itself becomes too predictable to enjoy. One
of the reasons sports (and sports betting) is so popular is because of the
high degree of unpredictability.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;If players are getting more and more powerful over time, they could become
so powerful they are able to drive the ball to the endzone every possession.&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;The evidence agrees with the theory offensive plays are gaining more yards per
play than the year prior. This relationship has a high degree of statistical
signifance (the probability the relationship is random being 2.183e-07).
Admittedly, the advancement is very small, about 0.026 yards per year.&lt;/p&gt;

&lt;p&gt;Correspondingly, a strong and positive relationship was found between the likelihood
of a play resulting in a conversion over time. The likelihood a play results
in a first down, year over year, is increasing by 0.128% (in 2013, the
percentage of plays resulting in a first down was 27.8%). Again, this is a
rather trivial quantity, but the relationship shows a high degree of
statistical significance (the likelihood this relationship is actually random
is 1.782e-06).&lt;/p&gt;

&lt;p&gt;So, long term, as football players get better and better, the game will get more and
more predictable and less fun to watch.&lt;/p&gt;

&lt;style&gt;

  .axis path,
  .axis line {
    fill: none;
    stroke: #000;
    shape-rendering: crispEdges;
  }

&lt;/style&gt;

&lt;script type=&quot;text/javascript&quot;&gt;
  
  var margin = {top: 20, right: 20, bottom: 30, left: 60},
          width = document.getElementsByClassName(&#39;post&#39;)[0].clientWidth - margin.left - margin.right,
          height = 500 - margin.top - margin.bottom;

      /* 
       * value accessor - returns the value to encode for a given data object.
       * scale - maps value to a visual display encoding, such as a pixel position.
       * map function - maps from data value to display value
       * axis - sets up axis
       */ 

      // setup x 
      var xValue = function(d) { return d.Year; }, // data -&gt; value
          xScale = d3.scale.linear().range([0,width])
          xMap = function(d) { return xScale(xValue(d));}, // data -&gt; display
          xAxis = d3.svg.axis().scale(xScale).orient(&quot;bottom&quot;);

      // setup y
      var yValue = function(d) { return d.Yds;}, // data -&gt; value
          yScale = d3.scale.linear().range([height, 0]), // value -&gt; display
          yMap = function(d) { return yScale(yValue(d));}, // data -&gt; display
          yAxis = d3.svg.axis().scale(yScale).orient(&quot;left&quot;);

      // add the graph canvas to the body of the webpage
      var svg = d3.select(&quot;.post-content&quot;).append(&quot;svg&quot;)
          .attr(&quot;width&quot;, width + margin.left + margin.right)
          .attr(&quot;height&quot;, height + margin.top + margin.bottom)
        .append(&quot;g&quot;)
          .attr(&quot;transform&quot;, &quot;translate(&quot; + margin.left + &quot;,&quot; + margin.top + &quot;)&quot;);

      // load data
      d3.csv(&quot;/data/NFL-YrAggregates.csv&quot;, function(error, data) {
        // change string (from CSV) into number format
        data.forEach(function(d) {
          d.Yds = +d.Yds;
          d.Year = +d.Year;
        });

        // don&#39;t want dots overlapping axis, so add in buffer to data domain
        xScale.domain([d3.min(data, xValue)-1, d3.max(data, xValue)+1]);
        yScale.domain([d3.min(data, yValue)-.05, d3.max(data, yValue)+.05]);

        // x-axis
        svg.append(&quot;g&quot;)
            .attr(&quot;class&quot;, &quot;x axis&quot;)
            .attr(&quot;transform&quot;, &quot;translate(0,&quot; + height + &quot;)&quot;)
            .call(xAxis.tickFormat(d3.format(&quot;j&quot;)))
          .append(&quot;text&quot;)
            .attr(&quot;class&quot;, &quot;label&quot;)
            .attr(&quot;x&quot;, width)
            .attr(&quot;y&quot;, -6)
            .style(&quot;text-anchor&quot;, &quot;end&quot;)
            .text(&quot;Year&quot;);

        // y-axis
        svg.append(&quot;g&quot;)
            .attr(&quot;class&quot;, &quot;y axis&quot;)
            .call(yAxis)
          .append(&quot;text&quot;)
            .attr(&quot;class&quot;, &quot;label&quot;)
            .attr(&quot;transform&quot;, &quot;rotate(-90)&quot;)
            .attr(&quot;y&quot;, 6)
            .attr(&quot;dy&quot;, &quot;.71em&quot;)
            .style(&quot;text-anchor&quot;, &quot;end&quot;)
            .text(&quot;Avg offensive yards per play&quot;);


        // draw dots
        svg.selectAll(&quot;.dot&quot;)
            .data(data)
          .enter().append(&quot;circle&quot;)
            .attr(&quot;class&quot;, &quot;dot&quot;)
            .attr(&quot;r&quot;, 3.5)
            .attr(&quot;cx&quot;, xMap)
            .attr(&quot;cy&quot;, yMap)
            .style(&quot;fill&quot;, &quot;rgb(102,163,217)&quot;)
      });

&lt;/script&gt;

&lt;p&gt;&lt;br /&gt;
&lt;br /&gt;&lt;/p&gt;

</description>
        <pubDate>Sat, 22 Nov 2014 15:28:45 -0500</pubDate>
        <link>http://aimeeb.com/nfl/d3/statistics/2014/11/22/nfl-avg-yds-per-play.html</link>
        <guid isPermaLink="true">http://aimeeb.com/nfl/d3/statistics/2014/11/22/nfl-avg-yds-per-play.html</guid>
        
        
        <category>nfl</category>
        
        <category>d3</category>
        
        <category>statistics</category>
        
      </item>
    
  </channel>
</rss>
